Navigation Links
BSP Pharma Inc., Makers of FlexNow(TM) Joint Formula Sign Distribution Deal with Vitamin Shoppe and GNC

The most powerful inflammation fighter of any known botanical now widely


EGG HARBOR TOWNSHIP., N.J., Sept. 4 /PRNewswire/ -- BSP Pharma Inc., based in Egg Harbor Township, NJ, has announced the distribution of its new, all natural dietary supplement FlexNow(TM) Joint Formula in Vitamin Shoppe stores ( nationally as well as at select GNC stores ( throughout the country.

"With the national launch of FlexNow Joint Formula earlier this year, we are continuing to see success and demand for our product," stated Leonard P. Smith, CEO and President of BSP Pharma Inc. "Distribution in Vitamin Shoppe and select GNC outlets introduces FlexNow to a larger market and to those suffering from chronic joint discomfort," he added.

FlexNow(TM) Joint Formula is an all natural dietary supplement made with one ingredient: shea nut triterpenes, the most powerful inflammation fighter of any known botanical. Harvested in the wild in West Africa, the shea nut (the nut is actually the pit of the shea fruit) which produces shea oil has been used for centuries as a food product and more recently as an effective additive to cosmetics and moisturizers (shea butter). Research revealed that the shea nut contains the most unique complex of Nature's Inflammation Fighters(TM), triterpenes, of any known botanical.

Since inflammation is a primary contributor to joint problems, BSP Pharma conducted pharmacological and clinical research into the anti-inflammatory properties of triterpene esters found in the shea nut triterpenes. Positive results led the way to the development of FlexNow Joint Formula. Reports on the clinical studies are available at: Extensive research on shea nut triterpene extract also proved safety, including lack of gastric lesions.

FlexNow Joint Formula was one of only seven dietary supplement products accepted by the FDA in 2004 to meet all the safety requirements under the Dietary Supplement Health and Education Act. FlexNow offers a full guarantee, complete relief in 30 days or complete refund.

About BSP Pharma

BSP Pharma Inc., a subsidiary of BSP Pharma A/S of Denmark, is based in Egg Harbor Township, NJ, and was formed in 2005 to bring the remarkable shea nut health products to market. BSP's CEO and President Leonard P. Smith has held senior level positions in the nutraceutical and pharmaceutical industry for more than 20 years. At Lactaid Inc. he led the company's flagship product, Lactaid(R), through explosive growth. While running Lactaid(R), Smith developed Beano(R), a successful legend in the nutraceutical field. For product availability and additional information visit the company's website

Lactaid(R) is a registered trademark of Johnson & Johnson.

Beano(R) is a registered trademark of GlaxoSmithKline.

SOURCE BSP Pharma Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today ... a patient who developed lymphedema after being treated for breast cancer benefitted from an ... paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... NEWPORT BEACH, Calif. , June 23, 2016 /PRNewswire/ ... offering new biological discoveries to the medical community, has ... and co-founder Matthew Nunez . "We ... provide us with the capital we need to meet ... funding will essentially provide us the runway to complete ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... has initiated coverage on the following equities: Infinity Pharmaceuticals ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... Learn more about these stocks by accessing their free trade ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
Breaking Biology Technology:
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):